A detailed history of High Net Worth Advisory Group LLC transactions in Argenx Se stock. As of the latest transaction made, High Net Worth Advisory Group LLC holds 600 shares of ARGX stock, worth $338,538. This represents 0.09% of its overall portfolio holdings.

Number of Shares
600
Previous 600 -0.0%
Holding current value
$338,538
Previous $258,000 25.97%
% of portfolio
0.09%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$269.58 - $378.88 $26,958 - $37,888
100 Added 20.0%
600 $227,000
Q4 2021

Apr 27, 2022

BUY
$272.01 - $353.03 $136,005 - $176,515
500 New
500 $156,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track High Net Worth Advisory Group LLC Portfolio

Follow High Net Worth Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Net Worth Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Net Worth Advisory Group LLC with notifications on news.